This report contains market size and forecasts of S1P Receptor Modulator Drugs in Global, including the following market information:
Global S1P Receptor Modulator Drugs Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global S1P Receptor Modulator Drugs market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Fingolimod Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of S1P Receptor Modulator Drugs include Novartis International AG, Bristol Myers Squibb, Pfizer Inc., Sanofi SA, Merck & Co., Inc., Biogen Inc. and Roche Holding AG, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the S1P Receptor Modulator Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global S1P Receptor Modulator Drugs Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global S1P Receptor Modulator Drugs Market Segment Percentages, by Type, 2022 (%)
Fingolimod
Ozanimod
Siponimod
Others
Global S1P Receptor Modulator Drugs Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global S1P Receptor Modulator Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Global S1P Receptor Modulator Drugs Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global S1P Receptor Modulator Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies S1P Receptor Modulator Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies S1P Receptor Modulator Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis International AG
Bristol Myers Squibb
Pfizer Inc.
Sanofi SA
Merck & Co., Inc.
Biogen Inc.
Roche Holding AG
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 S1P Receptor Modulator Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global S1P Receptor Modulator Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global S1P Receptor Modulator Drugs Overall Market Size
2.1 Global S1P Receptor Modulator Drugs Market Size: 2022 VS 2030
2.2 Global S1P Receptor Modulator Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top S1P Receptor Modulator Drugs Players in Global Market
3.2 Top Global S1P Receptor Modulator Drugs Companies Ranked by Revenue
3.3 Global S1P Receptor Modulator Drugs Revenue by Companies
3.4 Top 3 and Top 5 S1P Receptor Modulator Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies S1P Receptor Modulator Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 S1P Receptor Modulator Drugs Players in Global Market
3.6.1 List of Global Tier 1 S1P Receptor Modulator Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 S1P Receptor Modulator Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global S1P Receptor Modulator Drugs Market Size Markets, 2022 & 2030
4.1.2 Fingolimod
4.1.3 Ozanimod
4.1.4 Siponimod
4.1.5 Others
4.2 By Type - Global S1P Receptor Modulator Drugs Revenue & Forecasts
4.2.1 By Type - Global S1P Receptor Modulator Drugs Revenue, 2018-2023
4.2.2 By Type - Global S1P Receptor Modulator Drugs Revenue, 2023-2030
4.2.3 By Type - Global S1P Receptor Modulator Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global S1P Receptor Modulator Drugs Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.1.5 Others
5.2 By Application - Global S1P Receptor Modulator Drugs Revenue & Forecasts
5.2.1 By Application - Global S1P Receptor Modulator Drugs Revenue, 2018-2023
5.2.2 By Application - Global S1P Receptor Modulator Drugs Revenue, 2023-2030
5.2.3 By Application - Global S1P Receptor Modulator Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global S1P Receptor Modulator Drugs Market Size, 2022 & 2030
6.2 By Region - Global S1P Receptor Modulator Drugs Revenue & Forecasts
6.2.1 By Region - Global S1P Receptor Modulator Drugs Revenue, 2018-2023
6.2.2 By Region - Global S1P Receptor Modulator Drugs Revenue, 2023-2030
6.2.3 By Region - Global S1P Receptor Modulator Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America S1P Receptor Modulator Drugs Revenue, 2018-2030
6.3.2 US S1P Receptor Modulator Drugs Market Size, 2018-2030
6.3.3 Canada S1P Receptor Modulator Drugs Market Size, 2018-2030
6.3.4 Mexico S1P Receptor Modulator Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe S1P Receptor Modulator Drugs Revenue, 2018-2030
6.4.2 Germany S1P Receptor Modulator Drugs Market Size, 2018-2030
6.4.3 France S1P Receptor Modulator Drugs Market Size, 2018-2030
6.4.4 U.K. S1P Receptor Modulator Drugs Market Size, 2018-2030
6.4.5 Italy S1P Receptor Modulator Drugs Market Size, 2018-2030
6.4.6 Russia S1P Receptor Modulator Drugs Market Size, 2018-2030
6.4.7 Nordic Countries S1P Receptor Modulator Drugs Market Size, 2018-2030
6.4.8 Benelux S1P Receptor Modulator Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia S1P Receptor Modulator Drugs Revenue, 2018-2030
6.5.2 China S1P Receptor Modulator Drugs Market Size, 2018-2030
6.5.3 Japan S1P Receptor Modulator Drugs Market Size, 2018-2030
6.5.4 South Korea S1P Receptor Modulator Drugs Market Size, 2018-2030
6.5.5 Southeast Asia S1P Receptor Modulator Drugs Market Size, 2018-2030
6.5.6 India S1P Receptor Modulator Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America S1P Receptor Modulator Drugs Revenue, 2018-2030
6.6.2 Brazil S1P Receptor Modulator Drugs Market Size, 2018-2030
6.6.3 Argentina S1P Receptor Modulator Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa S1P Receptor Modulator Drugs Revenue, 2018-2030
6.7.2 Turkey S1P Receptor Modulator Drugs Market Size, 2018-2030
6.7.3 Israel S1P Receptor Modulator Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia S1P Receptor Modulator Drugs Market Size, 2018-2030
6.7.5 UAE S1P Receptor Modulator Drugs Market Size, 2018-2030
7 Players Profiles
7.1 Novartis International AG
7.1.1 Novartis International AG Corporate Summary
7.1.2 Novartis International AG Business Overview
7.1.3 Novartis International AG S1P Receptor Modulator Drugs Major Product Offerings
7.1.4 Novartis International AG S1P Receptor Modulator Drugs Revenue in Global Market (2018-2023)
7.1.5 Novartis International AG Key News
7.2 Bristol Myers Squibb
7.2.1 Bristol Myers Squibb Corporate Summary
7.2.2 Bristol Myers Squibb Business Overview
7.2.3 Bristol Myers Squibb S1P Receptor Modulator Drugs Major Product Offerings
7.2.4 Bristol Myers Squibb S1P Receptor Modulator Drugs Revenue in Global Market (2018-2023)
7.2.5 Bristol Myers Squibb Key News
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Corporate Summary
7.3.2 Pfizer Inc. Business Overview
7.3.3 Pfizer Inc. S1P Receptor Modulator Drugs Major Product Offerings
7.3.4 Pfizer Inc. S1P Receptor Modulator Drugs Revenue in Global Market (2018-2023)
7.3.5 Pfizer Inc. Key News
7.4 Sanofi SA
7.4.1 Sanofi SA Corporate Summary
7.4.2 Sanofi SA Business Overview
7.4.3 Sanofi SA S1P Receptor Modulator Drugs Major Product Offerings
7.4.4 Sanofi SA S1P Receptor Modulator Drugs Revenue in Global Market (2018-2023)
7.4.5 Sanofi SA Key News
7.5 Merck & Co., Inc.
7.5.1 Merck & Co., Inc. Corporate Summary
7.5.2 Merck & Co., Inc. Business Overview
7.5.3 Merck & Co., Inc. S1P Receptor Modulator Drugs Major Product Offerings
7.5.4 Merck & Co., Inc. S1P Receptor Modulator Drugs Revenue in Global Market (2018-2023)
7.5.5 Merck & Co., Inc. Key News
7.6 Biogen Inc.
7.6.1 Biogen Inc. Corporate Summary
7.6.2 Biogen Inc. Business Overview
7.6.3 Biogen Inc. S1P Receptor Modulator Drugs Major Product Offerings
7.6.4 Biogen Inc. S1P Receptor Modulator Drugs Revenue in Global Market (2018-2023)
7.6.5 Biogen Inc. Key News
7.7 Roche Holding AG
7.7.1 Roche Holding AG Corporate Summary
7.7.2 Roche Holding AG Business Overview
7.7.3 Roche Holding AG S1P Receptor Modulator Drugs Major Product Offerings
7.7.4 Roche Holding AG S1P Receptor Modulator Drugs Revenue in Global Market (2018-2023)
7.7.5 Roche Holding AG Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. S1P Receptor Modulator Drugs Market Opportunities & Trends in Global Market
Table 2. S1P Receptor Modulator Drugs Market Drivers in Global Market
Table 3. S1P Receptor Modulator Drugs Market Restraints in Global Market
Table 4. Key Players of S1P Receptor Modulator Drugs in Global Market
Table 5. Top S1P Receptor Modulator Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global S1P Receptor Modulator Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global S1P Receptor Modulator Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies S1P Receptor Modulator Drugs Product Type
Table 9. List of Global Tier 1 S1P Receptor Modulator Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 S1P Receptor Modulator Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - S1P Receptor Modulator Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - S1P Receptor Modulator Drugs Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - S1P Receptor Modulator Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - S1P Receptor Modulator Drugs Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global S1P Receptor Modulator Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global S1P Receptor Modulator Drugs Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2023-2030
Table 30. Novartis International AG Corporate Summary
Table 31. Novartis International AG S1P Receptor Modulator Drugs Product Offerings
Table 32. Novartis International AG S1P Receptor Modulator Drugs Revenue (US$, Mn), (2018-2023)
Table 33. Bristol Myers Squibb Corporate Summary
Table 34. Bristol Myers Squibb S1P Receptor Modulator Drugs Product Offerings
Table 35. Bristol Myers Squibb S1P Receptor Modulator Drugs Revenue (US$, Mn), (2018-2023)
Table 36. Pfizer Inc. Corporate Summary
Table 37. Pfizer Inc. S1P Receptor Modulator Drugs Product Offerings
Table 38. Pfizer Inc. S1P Receptor Modulator Drugs Revenue (US$, Mn), (2018-2023)
Table 39. Sanofi SA Corporate Summary
Table 40. Sanofi SA S1P Receptor Modulator Drugs Product Offerings
Table 41. Sanofi SA S1P Receptor Modulator Drugs Revenue (US$, Mn), (2018-2023)
Table 42. Merck & Co., Inc. Corporate Summary
Table 43. Merck & Co., Inc. S1P Receptor Modulator Drugs Product Offerings
Table 44. Merck & Co., Inc. S1P Receptor Modulator Drugs Revenue (US$, Mn), (2018-2023)
Table 45. Biogen Inc. Corporate Summary
Table 46. Biogen Inc. S1P Receptor Modulator Drugs Product Offerings
Table 47. Biogen Inc. S1P Receptor Modulator Drugs Revenue (US$, Mn), (2018-2023)
Table 48. Roche Holding AG Corporate Summary
Table 49. Roche Holding AG S1P Receptor Modulator Drugs Product Offerings
Table 50. Roche Holding AG S1P Receptor Modulator Drugs Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. S1P Receptor Modulator Drugs Segment by Type in 2022
Figure 2. S1P Receptor Modulator Drugs Segment by Application in 2022
Figure 3. Global S1P Receptor Modulator Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global S1P Receptor Modulator Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global S1P Receptor Modulator Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by S1P Receptor Modulator Drugs Revenue in 2022
Figure 8. By Type - Global S1P Receptor Modulator Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global S1P Receptor Modulator Drugs Revenue Market Share, 2018-2030
Figure 10. By Region - Global S1P Receptor Modulator Drugs Revenue Market Share, 2018-2030
Figure 11. By Country - North America S1P Receptor Modulator Drugs Revenue Market Share, 2018-2030
Figure 12. US S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 13. Canada S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe S1P Receptor Modulator Drugs Revenue Market Share, 2018-2030
Figure 16. Germany S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. France S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. Italy S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 20. Russia S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia S1P Receptor Modulator Drugs Revenue Market Share, 2018-2030
Figure 24. China S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Japan S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 28. India S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America S1P Receptor Modulator Drugs Revenue Market Share, 2018-2030
Figure 30. Brazil S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa S1P Receptor Modulator Drugs Revenue Market Share, 2018-2030
Figure 33. Turkey S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Israel S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. UAE S1P Receptor Modulator Drugs Revenue, (US$, Mn), 2018-2030
Figure 37. Novartis International AG S1P Receptor Modulator Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Bristol Myers Squibb S1P Receptor Modulator Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Pfizer Inc. S1P Receptor Modulator Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Sanofi SA S1P Receptor Modulator Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Merck & Co., Inc. S1P Receptor Modulator Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Biogen Inc. S1P Receptor Modulator Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Roche Holding AG S1P Receptor Modulator Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
